2025 IBD Pharmacist Virtual Symposium
Update on Pouchitis Management: Current Strategies and Emerging Therapies
Edward L. Barnes, MD, MPH
Katie Dunleavy, MB, BCh, BAO
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Ross M. Maltz, MD
Melissa Kirkpatrick, PharmD, BCACP
Complicated Crohn’s Disease Cases: Perianal Disease, Intra-abdominal Abscess, & Strictures
David A. Schwartz, MD
Ira Leeds, MD, FACS, FASCRS
Surgical Management of Inflammatory Bowel Disease
Michele Rubin, APN, CNS, CGRN
Psychosocial Issues in IBD
Alyse Bedell, PhD
Health Maintenance (Adult)
Mary Kate Preite, NP
Scripps Conference: New Advances in Inflammatory Bowel Disease
Health Disparities in IBD
Leybelis Padilla
Case Presentation: Inpatient IBD – Management of Acute Severe Ulcerative Colitis
Rebecca Matro, MD
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc
Siddharth Singh, MD
Practical Use of Biomarkers in IBD – Clinical Guidelines
Benjamin L. Cohen, MD
Panel Discussion - Cohen, Matro, Worsey
Jonathan Worsey, MD, FACS, FRCS
Panel Discussion - Long, Padilla, Stidham
Millie D. Long, MD, MPH
Panel Case Presentations: How I Choose IBD Therapies - Dubinsky, Singh
Marla C Dubinsky, MD
Patient Perspective on Decision-Making in IBD
McKenna Plant
Positioning Therapies for Moderate to Severe CD
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.